rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-1-20
|
pubmed:abstractText |
Endothelin-1 (ET-1) is mitogenic and/or antiapoptotic in human cancers, and antagonists to ET-1 receptors are under evaluation for cancer treatment. Inhibition of ET-1 activation by the endothelin-converting enzymes 1(a)(-)(d) (ECE-1(a)(-)(d); EC 3.4.24.71) represents another approach to block the ET-1 effect in cancer. To evaluate this potential, we synthesized and characterized a series of low nanomolar nonpeptidic thiol-containing ECE-1 inhibitors, and evaluated their effect, as well as the effect of inhibitors for the related metalloproteases neprilysin (NEP; EC 3.4.24.11) and angiotensin-converting enzyme (ACE; EC 3.4.15.1), on human glioblastoma cell growth. Only ECE-1 inhibitors inhibited DNA synthesis by human glioblastoma cells. Exogenous addition of ET-1 or bigET-1 to glioblastoma cells did not counterbalance the growth inhibition elicited by ECE-1 inhibitors, suggesting that ECE-1 inhibitors block the proliferation of human glioblastoma cells most likely via a mechanism not involving extracellular production of ET-1. This class of molecules may thus represent novel therapeutic agents for the potential treatment of human cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Carbamates,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrazines,
http://linkedlifedata.com/resource/pubmed/chemical/Metalloendopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Proline,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfhydryl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/endothelin-converting enzyme
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-2623
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
483-98
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15658862-Antineoplastic Agents,
pubmed-meshheading:15658862-Aspartic Acid Endopeptidases,
pubmed-meshheading:15658862-Carbamates,
pubmed-meshheading:15658862-Cell Line, Tumor,
pubmed-meshheading:15658862-Cell Proliferation,
pubmed-meshheading:15658862-Central Nervous System Neoplasms,
pubmed-meshheading:15658862-Drug Screening Assays, Antitumor,
pubmed-meshheading:15658862-Endothelin-1,
pubmed-meshheading:15658862-Glioblastoma,
pubmed-meshheading:15658862-Humans,
pubmed-meshheading:15658862-Hydrazines,
pubmed-meshheading:15658862-Metalloendopeptidases,
pubmed-meshheading:15658862-Proline,
pubmed-meshheading:15658862-Pyrimidines,
pubmed-meshheading:15658862-Pyrrolidines,
pubmed-meshheading:15658862-Structure-Activity Relationship,
pubmed-meshheading:15658862-Sulfhydryl Compounds
|
pubmed:year |
2005
|
pubmed:articleTitle |
Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells.
|
pubmed:affiliation |
University Institute of Pathology, University of Lausanne, Bugnon 25, CH1011 Lausanne, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|